- Home
- PCRX vs SMBK Comparison
PCRX vs SMBK Comparison
Compare PCRX & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SMBK
- Stock Information
- Founded
- PCRX 2006
- SMBK N/A
- Country
- PCRX United States
- SMBK United States
- Employees
- PCRX N/A
- SMBK N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SMBK Major Banks
- Sector
- PCRX Health Care
- SMBK Finance
- Exchange
- PCRX Nasdaq
- SMBK Nasdaq
- Market Cap
- PCRX 604.7M
- SMBK 575.5M
- IPO Year
- PCRX 2011
- SMBK N/A
- Fundamental
- Price
- PCRX $20.55
- SMBK $30.50
- Analyst Decision
- PCRX Buy
- SMBK Buy
- Analyst Count
- PCRX 10
- SMBK 5
- Target Price
- PCRX $27.60
- SMBK $28.20
- AVG Volume (30 Days)
- PCRX 779.4K
- SMBK 52.6K
- Earning Date
- PCRX 02-27-2025
- SMBK 01-21-2025
- Dividend Yield
- PCRX N/A
- SMBK 1.08%
- EPS Growth
- PCRX N/A
- SMBK N/A
- EPS
- PCRX N/A
- SMBK 1.93
- Revenue
- PCRX $694,957,000.00
- SMBK $159,196,000.00
- Revenue This Year
- PCRX $4.83
- SMBK N/A
- Revenue Next Year
- PCRX $2.16
- SMBK $12.16
- P/E Ratio
- PCRX N/A
- SMBK $15.40
- Revenue Growth
- PCRX 4.40
- SMBK 2.18
- 52 Week Low
- PCRX $11.16
- SMBK $19.00
- 52 Week High
- PCRX $34.01
- SMBK $37.72
- Technical
- Relative Strength Index (RSI)
- PCRX 61.87
- SMBK 37.29
- Support Level
- PCRX $18.18
- SMBK $28.86
- Resistance Level
- PCRX $22.36
- SMBK $31.71
- Average True Range (ATR)
- PCRX 0.97
- SMBK 0.69
- MACD
- PCRX 0.11
- SMBK -0.06
- Stochastic Oscillator
- PCRX 56.80
- SMBK 57.54
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.